Nakamoto Packs (7811) · InitiativeRestated
Differentiation in Medical and Pharmaceutical Products Through a Broader Product Lineup
First written in FY2017. 2 of 3 entries say "Restated". Latest entry: FY2019.
3entries
3years
0from disclosures
How it moved
Same theme, other companies
Market Share Expansion through Product DifferentiationA theme 27 companies write about · 0 as a headwind · 27 as a tailwind
The whole theme swung hardest in 2025: 4 of 9 companies on the "Worse" side.
12 other companies' latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 27 companies compared. The sentences above are computed from all 27.Full recordFilings, disclosures and news, newest first
- FY2019RestatedAnnual report
「We will pursue differentiation by further reducing product costs, expanding our lineup and meeting customers' detailed needs.」
The company continues to differentiate itself in the medical and pharmaceutical fields through cost reductions, product-lineup expansion and responses to customer needs. - FY2018RestatedAnnual report
「We will pursue differentiation by expanding our product lineup to meet customers' detailed needs.」
The company continues to differentiate itself in the medical and pharmaceutical fields by addressing customer needs and expanding its product lineup. - FY2017First statedAnnual report
「To expand orders for NS SEPA, our proprietary brand, and gravure printing, we will differentiate ourselves by expanding our product lineup to meet customers’ detailed needs.」
The company has outlined measures to differentiate itself in the medical and pharmaceutical fields by addressing customers' detailed needs and expanding its product lineup.